Board reasoning
The Board found that the Veteran’s bladder dysfunction requiring absorbent materials more than four times daily persisted throughout the period after the cessation of the total rating, based on credible lay and medical evidence, including urology records and prior exams. It concluded that, by the benefit of the doubt, a 60% rating was warranted for the entire period from December 1, 2013, to February 11, 2021.
Issues
- initial 60 percent rating for prostate cancer residuals manifested by bladder dysfunction from December 1, 2013, to February 11, 2021Granted
Extracted with gpt-5-nano-2025-08-07. Citations are kept only when they appear in the decision text.